Bhutan vs Syria: HIV-positive TB patients on ART (antiretroviral therapy)
Bhutan
100.0%
in 2024
Syria
100.0%
in 2021
Bhutan rank
1st
Syria rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Bhutan
- Syria
How they compare
Bhutan currently reports 100.0% against 100.0% in Syria, a difference of 0.0%.
Across all 8 years both countries report, Syria has been ahead every year.
Bhutan ranks 1st and Syria ranks 1st of 144 countries.
Syria has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bhutan | Syria | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 91.7% | 100.0% | 8.3% | Syria |
| 2020s | 100.0% | 100.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Bhutan or Syria?
- Bhutan, at 100.0% against 100.0% in Syria as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Bhutan and Syria?
- 0.0%, with Bhutan ahead.
- How many years of comparable data are there for Bhutan and Syria?
- 8 years are reported by both, from 2013 to 2021.
- How do Bhutan and Syria rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Bhutan ranks 1st and Syria ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.